|
|
|
AFRICA: 3-in-1 ARV to ease adherence
[This report does not necessarily reflect the views of the United Nations]
JOHANNESBURG, 6 July (PLUSNEWS) - A generic 3-in-1 anti-AIDS pill, recently approved by the US Food and Drug Administration (FDA), could greatly ease daily treatment regimens for patients in developing countries, a senior US official said on Wednesday.
Although it was not yet clear how cost-effective the new drug would be, HIV-positive people would take only one pill twice a day, which "should facilitate better therapies and better adherence", The New York Times quoted acting US Global AIDS Coordinator Mark Dybul as saying.
The fixed-dose combination tablet, manufactured by Aurobindo Pharma, an Indian generic drug company, will be available for purchase and distribution under the President's Emergency Plan for AIDS Relief (PEPFAR).
PEPFAR is a $15 billion initiative, launched by US President George W. Bush in 2003, for the prevention, treatment and care of HIV/AIDS in 12 African countries and the Caribbean.
[ENDS]
:: MORE NEWS BRIEFS ::
|
|
|
|
|
|
|
|
|
|
| Links |
· AIDS Media Center
|
· The Global Fund to fight AIDS, Tuberculosis & Malaria
|
· International Community of Women Living with HIV/AIDS
|
· AEGIS
|
· International HIV/AIDS Alliance
|
PlusNews does not take responsibility for info in links supplied.
|
|
|
|
|
[Back] [Home Page]
Click here to send any feedback, comments or questions you have about PlusNews Website or if you prefer you can send an Email to Webmaster
Copyright © IRIN 2006
The material contained on www.PlusNews.org comes to you via IRIN, a UN humanitarian news and information service, but may not necessarily reflect the views of the United Nations or its agencies.
All PlusNews material may be reposted or reprinted free-of-charge; refer to the IRIN copyright page for conditions of use. IRIN is a project of the UN Office for the Coordination of Humanitarian Affairs.
|
